Chrysin promotes tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced apoptosis in human cancer cell lines

Toxicology in Vitro

Volumn 25, Issue 3, 2011, Pages 630-635

  Li, Xin ^a   Wang, Jian Ning ^b   Huang, Jun Ming ^a   Xiong, Xi Kun ^a   Chen, Mei Fen ^a   Ong, Choon Nam ^c   Shen, Han Ming ^c   Yang, Xing Fen ^a  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Cancer; Chrysin; TNF related apoptosis inducing ligand (TRAIL)

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE INHIBITOR; CHRYSIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL STRAIN HCT116; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME DEGRADATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 8; CELL SURVIVAL; DRUG COMBINATIONS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; FLAVONOIDS; HCT116 CELLS; HELA CELLS; HEP G2 CELLS; HUMANS; NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 79952037283     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.12.013     Document Type: Article

References (28)

1. Ai X.H., Zheng X., Tang X.Q., Sun L., Zhang Y.Q., Qin Y., Liu H.Q., Xia H., Cao J.G. Induction of apoptosis of human gastric carcinoma SGC-7901 cell line by 5,7-dihydroxy-8-nitrochrysin in vitro. World Journal of Gastroenterology 2007, 13:3824-3828.
2. Arts I.C. A review of the epidemiological evidence on tea, flavonoids, and lung cancer. The Journal of Nutrition 2008, 138:1561S-1566S.
3. Ashkenazi A., Pai R.C., Fong S., Leung S., Lawrence D.A., Marsters S.A., Blackie C., Chang L., McMurtrey A.E., Hebert A., DeForge L., Koumenis I.L., Lewis D., Harris L., Bussiere J., Koeppen H., Shahrokh Z., Schwall R.H. Safety and antitumor activity of recombinant soluble Apo2 ligand. The Journal of Clinical Investigation 1999, 104:155-162.
4. Darzynkiewicz Z., Bedner E., Traganos F., Murakami T. Critical aspects in the analysis of apoptosis and necrosis. Human Cell 1998, 11:3-12.
5. Huang Y., Sheikh M.S. TRAIL death receptors and cancer therapeutics. Toxicology and Applied Pharmacology 2007, 224:284-289.
6. Lapidot T., Walker M.D., Kanner J. Antioxidant and prooxidant effects of phenolics on pancreatic beta-cells in vitro. Journal of Agricultural and Food Chemistry 2002, 50:7220-7225.
7. LeBlanc H.N., Ashkenazi A. Apo2L/TRAIL and its death and decoy receptors. Cell Death and Differentiation 2003, 10:66-75.
8. Li C.W., Cai Bing C.C.-b., Han Bing D.D.-q., Chen Ying-jie Aromatic chemical constituents of Choerospondias axillaries and their in vitro antitumor activity. Chinese Journal of Medicinal Chemistry 2005, 15:5.
9. Li X., Huang Q., Ong C.N., Yang X.F., Shen H.M. Chrysin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells via suppression of nuclear factor-kappaB. Cancer Letters 2010, 293:109-116.
10. Miyamoto S., Kohno H., Suzuki R., Sugie S., Murakami A., Ohigashi H., Tanaka T. Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats. Oncology Reports 2006, 15:1169-1173.
11. Park O.J., Surh Y.J. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicology Letters 2004, 150:43-56.
12. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. The Journal of Nutritional Biochemistry 2007, 18:427-442.
13. Romier B., Van De Walle J., During A., Larondelle Y., Schneider Y.J. Modulation of signalling nuclear factor-kappaB activation pathway by polyphenols in human intestinal Caco-2 cells. The British Journal of Nutrition 2008, 100:542-551.
14. Shankar S., Srivastava R.K. Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications. Drug Resistance Updates 2004, 7:139-156.
15. Shen H.M., Tergaonkar V. NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis 2009, 14:348-363.
16. Shen H., Yang C., Liu J., Ong C. Dual role of glutathione in selenite-induced oxidative stress and apoptosis in human hepatoma cells. Free Radical Biology and Medicine 2000, 28:1115-1124.
17. Sheridan J.P., Marsters S.A., Pitti R.M., Gurney A., Skubatch M., Baldwin D., Ramakrishnan L., Gray C.L., Baker K., Wood W.I., Goddard A.D., Godowski P., Ashkenazi A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science (New York) 1997, 277:818-821.
18. Shi R.X., Ong C.N., Shen H.M. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Cancer Research 2005, 65:7815-7823.
19. Shi R., Huang Q., Zhu X., Ong Y.B., Zhao B., Lu J., Ong C.N., Shen H.M. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization. Molecular Cancer Therapeutics 2007, 6:1338-1347.
20. Son Y.G., Kim E.H., Kim J.Y., Kim S.U., Kwon T.K., Yoon A.R., Yun C.O., Choi K.S. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. Cancer Research 2007, 67:8274-8284.
21. Weng M.S., Ho Y.S., Lin J.K. Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1 expression: involvement of p38 mitogen-activated protein kinase. Biochemical Pharmacology 2005, 69:1815-1827.
22. Woo K.J., Jeong Y.J., Park J.W., Kwon T.K. Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells. Biochemical and Biophysical Research Communications 2004, 325:1215-1222.
23. Zhang L., Fang B. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Therapy 2005, 12:228-237.
24. Zhang T., Chen X., Qu L., Wu J., Cui R., Zhao Y. Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells. Bioorganic and Medicinal Chemistry 2004, 12:6097-6105.
25. Zhang Q., Zhao X.H., Wang Z.J. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food and Chemical Toxicology 2008, 46:2042-2053.
26. Zhang Q., Zhao X.H., Wang Z.J. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicology In Vitro 2009, 23:797-807.
27. Zhou J., Lu G.D., Ong C.S., Ong C.N., Shen H.M. Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation. Molecular Cancer Therapeutics 2008, 7:2170-2180.
28. Zhou Xi-qin, L.H., Lu Xin-hua, Cai Shao-qing, Wang Bin, Zhao Yu-ying, 2009. Flavonoids from Scutellaria baicalensis and their bioactivities. Journal of Peking University (Health Sciences) 41, 7.